Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. - Test2 - elhamkhani - TriplyDB

Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo.

Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo.

http://www.wikidata.org/entity/Q45061639

about

Novel biomarkers of arterial and venous ischemia in microvascular flaps Structural and functional investigations of the murine cavernosal nerve: a model system for serial spatio-temporal study of autonomic neuropathy.The opiorphin gene (ProL1) and its homologues function in erectile physiology.Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.Reversal of diabetic vasculopathy in a rat model of type 1 diabetes by opiorphin-related peptides Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.Variable coding sequence protein A1 as a marker for erectile dysfunction Diabetes-induced changes in the alternative splicing of the slo gene in corporal tissue.Gene transfer for the therapy of erectile dysfunction: progress in the 21st century.Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.Testosterone regulates erectile function and Vcsa1 expression in the corpora of rats.Sulfonylurea receptor as a target for molecular imaging of pancreas beta cells with (99m)Tc-DTPA-glipizide.Emerging gene and stem cell therapies for the treatment of erectile dysfunction.Gene therapy as future treatment of erectile dysfunction Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED.Emerging tools for erectile dysfunction: a role for regenerative medicine.Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha.Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo.Amplified NO/cGMP-mediated relaxation and ryanodine receptor-to-BKCa channel signalling in corpus cavernosum smooth muscle from phospholamban knockout mice Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat Silencing MaxiK activity in corporal smooth muscle cells initiates compensatory mechanisms to maintain calcium homeostasis.NS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels, enhances erectile responses in rats.Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model.Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel.A synthetic erectile optogenetic stimulator enabling blue-light-inducible penile erection.

P2860

Q28535317-2BA3B88F-0CC4-4071-BA45-05C2D661657B Q33279677-17D9869E-C6ED-4257-9598-1F2A84BBD3A9 Q33857635-D021494C-C3F7-405D-B6F2-41F49C6FBB4D Q34482043-085F3082-194C-4038-9D5C-A054684172D3 Q35395573-B5F81B5E-5AA3-4D5F-A1F0-98428ED226C9 Q35545755-072FD0E0-8527-4D5C-92D2-0C5E3D2F3734 Q36052371-F25D031B-4006-4442-BF87-BE5D68100DF6 Q36082094-D09FAA33-C296-4B2D-83CF-0B41FC33C1E4 Q36169357-37ADC88E-6D0A-4BE5-BF0F-5FB69F150D98 Q36310656-6AFFE234-F32F-422A-ADC9-4BDFDC658CED Q36808094-430C09B7-1247-4788-B7D0-ED7D49DD68FC Q36836444-C4358F33-98EF-4520-9542-E4FD57EA7512 Q37222126-91E33AEE-A780-4EE9-BAF8-D84A99A209F1 Q37398362-8961E618-0842-42C3-AA63-A9B19E04AAD3 Q37692808-7A428EE6-3DA9-4C77-98D4-431091B39F4D Q37775988-F11FEC8A-6961-41D2-B6A9-FC069EBDB6C0 Q37933090-51A9CD8A-D78B-4D04-930E-FAA746820129 Q37972086-E9709C27-A1A3-4A4B-A42A-460B88D33A17 Q38028739-F2964AEA-5361-43C5-9E34-5DFD41154E9A Q39955631-9EE2DF02-B46C-4882-9006-1B5CE54FBA65 Q40234554-8A7DF9D5-5D97-4A8F-B78D-84B2A625B82A Q40330240-B00C24D1-7103-48E2-A5A2-083B9D49EA9E Q40726109-4F38A42C-C996-40D2-8CE1-5B5A546970A5 Q41819759-487C7395-50CD-4BD6-B369-86D9515AB8F0 Q42002134-2FE93712-1DE2-48B2-AE5B-657A9F34159C Q42093202-E9A0921E-8FEF-4CB9-8EEB-181DDE65FAD7 Q42628321-B09BA883-FECB-4ABD-8DA1-76C5B788FF4D Q45874502-7BBD6CC3-868D-447C-90F0-091EC81928D5 Q45875110-5A1305F2-25AD-405A-9A10-2F3ED584093A Q46601467-99B9C66F-935F-4D52-AD35-5748A17069DD Q50216367-B2E560B6-1D9B-46BE-B483-B03FA4B3F302

P2860

Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo.

http://www.wikidata.org/entity/Q45061639

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Intracorporal injection of hSl ...... Z-diabetic F-344 rats in vivo.

@en

Intracorporal injection of hSl ...... Z-diabetic F-344 rats in vivo.

@nl

type

label

Intracorporal injection of hSl ...... Z-diabetic F-344 rats in vivo.

@en

Intracorporal injection of hSl ...... Z-diabetic F-344 rats in vivo.

@nl

prefLabel

Intracorporal injection of hSl ...... Z-diabetic F-344 rats in vivo.

@en

Intracorporal injection of hSl ...... Z-diabetic F-344 rats in vivo.

@nl

P1433

Q45061639-14CA8AA2-7163-4F63-98F2-4495280FD40E

P1476

Q45061639-8CB48C72-00B2-4F70-91DC-0A96D31E3795

P2093

Q45061639-0FC41FA4-80AC-415F-9699-CEA6EC99AF25

Q45061639-11A7A267-A5C1-41A5-BA06-4187CD898031

Q45061639-4A19FA42-AE0E-4DF7-A07B-065E96B4F4C9

Q45061639-6100A00C-B7F4-4E11-82B9-8051228618FA

Q45061639-6464BA55-6BF7-4014-B86A-55DD934A2590

Q45061639-8876F3C5-8E1E-424F-890E-30E522BC29E0

Q45061639-964C6486-12BC-4569-B81B-CCEF827CD971

Q45061639-BD3C9668-CD7D-41D3-9B7C-7622119906A8

Q45061639-FF6DC3B7-587D-49B6-A312-FCF5F45DBE93

P2860

Q45061639-14B1F48B-DF6C-4BA4-ACD9-147BD076ADB1

Q45061639-1E117B49-373A-4267-9D18-6973AF2940D5

Q45061639-29AE87CF-9B27-4228-A49B-3E3A9BEAFFDB

Q45061639-3A0BEC65-BA6F-4544-A22F-5AB3A65A8935

Q45061639-4A0F3F68-874A-4A11-94B1-424BD3C6638E

Q45061639-599B763D-9E95-4363-AA86-02A15111DA48

Q45061639-69440019-1D94-4C6C-9E9D-73EC4069A971

Q45061639-79EB8603-FB66-4E02-9331-20D10BDBACCF

Q45061639-873A74B6-5DBC-4939-BB6B-5C1A4FE9AEA0

Q45061639-A1EB4D3B-2E02-49B6-A588-3455259E4BA5

P304

Q45061639-FC9DE7EF-F3F3-4F65-966F-F3E860FCAF19

P31

Q45061639-15AC1889-6C07-4C20-9DFA-0A59BBDA0618

P356

Q45061639-F52346AA-A0DD-4BA7-B27B-691782FDAD29

P433

Q45061639-812283B9-7331-44E1-B77B-E93241E6C32D

P478

Q45061639-864E4AE7-4870-43A2-9FA7-BE812BFB19A4

P50

Q45061639-4675E536-27CB-490D-8F20-ED5A7A548F24

P577

Q45061639-3CA19920-20CD-449F-B42C-03A48EFD22D3

P5875

Q45061639-2BBAC8C0-C78D-44C9-9C76-D440070B75EA

P698

Q45061639-40B22D95-BE61-4564-AAA0-7E0691618FAA

P356

AJPHEART.00792.2003

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Intracorporal injection of hSl ...... TZ-diabetic F-344 rats in vivo

@en

P2093

Arnold Melman

http://www.w3.org/2001/XMLSchema#string

Cristian Santizo

http://www.w3.org/2001/XMLSchema#string

George J Christ

http://www.w3.org/2001/XMLSchema#string

Masha Salman

http://www.w3.org/2001/XMLSchema#string

Nancy Day

http://www.w3.org/2001/XMLSchema#string

Ron Bakal

http://www.w3.org/2001/XMLSchema#string

Theresa Sclafani

http://www.w3.org/2001/XMLSchema#string

Weixin Zhao

http://www.w3.org/2001/XMLSchema#string

Yoshi Sato

http://www.w3.org/2001/XMLSchema#string

P2860

A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin

Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel

Potassium channels: from scorpion venoms to high-resolution structure.

Potassium channel function in vascular disease.

Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction.

Gene therapy strategies for urological dysfunction.

Physiological roles for K+ channels and gap junctions in urogenital smooth muscle: implications for improved understanding of urogenital function, disease and therapy.

Peripheral channelopathies as targets for potassium channel openers.

Gene therapy: future therapy for erectile dysfunction.

Detection and implications of potassium channel alterations.

P304

H1544-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00792.2003

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P50

Kelvin P Davies

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8344090

http://www.w3.org/2001/XMLSchema#string

P698

15371262

http://www.w3.org/2001/XMLSchema#string